Full-Time

Contracts Manager II

R&D

Posted on 3/16/2025

Exelixis

Exelixis

1,001-5,000 employees

Develops and commercializes cancer therapies

Compensation Overview

$110k - $156k/yr

+ Bonus

Mid, Senior

Alameda, CA, USA

This is an onsite role (Monday through Friday) based at our location in Alameda, CA.

Category
Legal
Contract Management
Legal & Compliance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • BS/BA degree in a related discipline and five years of related experience.
  • JD preferred and two years of related experience.
  • Thorough understanding of the contract management process, including tracking, negotiation, approval, and signature processes.
  • Ability to work both independently and effectively across a variety of functional groups (such as Research and Development, CMC, Pharmaceutical Supply Chain, and Clinical) and all levels of management.
  • Clear and concise verbal and written communication skills; must have excellent interpersonal communication skills.
  • Strong computer skills (e.g., Microsoft Word, Excel, and PowerPoint).
  • Must be detail-oriented and have strong organizational skills.
  • Ability to handle multiple tasks simultaneously.
  • Ability to prioritize; must be responsible and conscientious.
  • Ability to work under pressure to meet specific deadlines.
  • Dedication to quality and reliability in all work tasks.
Responsibilities
  • Draft, negotiate, and manage a wide range of contracts (which may include confidentiality agreements, consulting and service agreements, materials transfer agreements, research agreements, clinical study agreements, and various vendor services agreements) under close supervision of senior attorneys.
  • Advise and troubleshoot on existing agreements under the supervision of senior attorneys.
  • Define risks related to contracts documents and relationships, and be able to communicate those risks to appropriate internal decision-makers for discussion and resolution.
  • Interact with various internal clients effectively to address legal and business questions.
  • Handle miscellaneous legal tasks on an as needed basis under the direction of senior attorneys.
  • Maintain and track the status for contracts.
  • Provide support to in-house attorneys as requested.
Desired Qualifications
  • Two to three years of in-house experience at a biotechnology, pharmaceutical or high-tech company, with a focus on contract drafting and negotiation.
  • Working knowledge of the drug discovery and development process and ability to understand risks and requirements associated with pharmaceutical contracting preferred.
  • Experience with or knowledge of paralegal support tasks, with a focus on intellectual property matters or corporate matters, preferred.

Exelixis develops and commercializes medicines specifically for cancer treatment. The company creates therapies that target various biological pathways and can be used in combination with other treatments, which helps to provide effective and manageable options for patients. Exelixis primarily focuses on advanced cancers, such as renal cell carcinoma, and engages in extensive research, clinical trials, and obtaining regulatory approvals to introduce new drugs to the market. Unlike many competitors, Exelixis emphasizes combination therapies that can enhance treatment effectiveness. The goal of Exelixis is to improve patient outcomes and offer hope for remission through its drug development efforts.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

1994

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic partnerships can expand Exelixis' pipeline and market reach.
  • AI-driven drug discovery accelerates identification of novel cancer targets for Exelixis.
  • Telemedicine improves patient monitoring, enhancing outcomes of Exelixis' therapies.

What critics are saying

  • Generic competition may reduce market share for CABOMETYX®.
  • Reliance on future drug approvals may not meet expectations.
  • Need for additional funding may indicate financial pressures.

What makes Exelixis unique

  • Exelixis focuses on combination regimens for advanced cancer treatment.
  • The company targets multiple pathways to create effective and durable cancer therapies.
  • Exelixis has a strong pipeline with four molecules in preclinical stages.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Employee Stock Purchase Plan

Company News

Medical Update Online
Mar 28th, 2025
Exelixis to present preclinical data for four pipeline molecules at AACR 2025

Exelixis to present preclinical data for four pipeline molecules at AACR 2025.

Defense World
Mar 9th, 2025
Proficio Capital Partners LLC Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)

Proficio Capital Partners LLC makes new investment in Exelixis, Inc. (NASDAQ:EXEL).

Stock Titan
Feb 13th, 2025
Exelixis to Participate in the Citi 2025 Virtual Oncology Leadership Summit

Exelixis to participate in the Citi 2025 Virtual Oncology Leadership Summit.

MarketBeat
Jan 7th, 2025
Range Financial Group LLC Invests $994,000 in Exelixis, Inc. (NASDAQ:EXEL)

Range Financial Group LLC invests $994,000 in Exelixis, Inc. (NASDAQ:EXEL).

Stock Titan
Jan 6th, 2025
Exelixis to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025

Exelixis to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.

INACTIVE